Inhibition/NN
of/IN
HIV-1/NN
replication/NN
and/CC
NF-kappa/NN
B/NN
activity/NN
by/IN
cysteine/NN
and/CC
cysteine/NN
derivatives/NNS
./.

HIV-1/NN
proviral/JJ
DNA/NN
contains/VBZ
two/CD
binding/VBG
sites/NNS
for/IN
the/DT
transcription/NN
factor/NN
NF-kappa/NN
B/NN
./.
=====
HIV-1-infected/JJ
individuals/NNS
have/VBP
,/,
on/IN
average/NN
,/,
abnormally/RB
high/JJ
levels/NNS
of/IN
tumour/NN
necrosis/NN
factor/NN
alpha/NN
(/(
TNF/NN
alpha/NN
)/)
and/CC
abnormally/RB
low/JJ
plasma/NN
cysteine/NN
levels/NNS
./.
=====
We/PRP
therefore/RB
investigated/VBD
the/DT
effects/NNS
of/IN
cysteine/NN
and/CC
related/JJ
thiols/NNS
on/IN
HIV-1/NN
replication/NN
and/CC
NF-kappa/NN
B/NN
expression/NN
./.
=====
The/DT
experiments/NNS
in/IN
this/DT
report/NN
show/VBP
that/IN
cysteine/NN
or/CC
N-acetylcysteine/NN
(/(
NAC/NN
)/)
raise/VBP
the/DT
intracellular/JJ
glutathione/NN
(/(
GSH/NN
)/)
level/NN
and/CC
inhibit/VBP
HIV-1/NN
replication/NN
in/IN
persistently/RB
infected/JJ
Molt-4/NN
and/CC
U937/NN
cells/NNS
./.
=====
However/RB
,/,
inhibition/NN
of/IN
HIV-1/NN
replication/NN
appears/VBZ
not/RB
to/TO
be/VB
directly/RB
correlated/VBN
with/IN
GSH/NN
levels/NNS
./.
=====
Cysteine/NN
and/CC
NAC/NN
also/RB
inhibit/VBP
NF-kappa/NN
B/NN
activity/NN
as/IN
determined/VBN
by/IN
electrophoretic/JJ
mobility/NN
shift/NN
assays/NNS
and/CC
chloramphenicol/NN
acetyl-transferase/NN
(/(
CAT/NN
)/)
gene/NN
expression/NN
under/IN
control/NN
of/IN
NF-kappa/NN
B/NN
binding/NN
sites/NNS
in/IN
uninfected/JJ
cells/NNS
./.
=====
This/DT
suggests/VBZ
that/IN
the/DT
cysteine/NN
deficiency/NN
in/IN
HIV-1-infected/JJ
individuals/NNS
may/MD
cause/VB
an/DT
over-expression/NN
of/IN
NF-kappa/NN
B-dependent/JJ
genes/NNS
and/CC
enhance/VB
HIV-1/NN
replication/NN
./.
=====
NAC/NN
may/MD
be/VB
considered/VBN
for/IN
the/DT
treatment/NN
of/IN
HIV-1-infected/JJ
individuals/NNS
./.